No results... Try to modify Your query or/and modify or reset the filters.
Most cited article - PubMed ID 28209331
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
The Lancet. Neurology.
2017 Apr ;
16 (4) :
271-281.
[epub] 20170211
